BRIEF-Rigel Pharmaceuticals Enters Amendment To Credit & Security Deal To Extend Maturity For Term Loans

Reuters04-12

April 12 (Reuters) - Rigel Pharmaceuticals Inc :

* RIGEL PHARMACEUTICALS: ON APRIL 11, ENTERED AMENDMENT TO CREDIT & SECURITY DEAL OF SEPT 27, 2019 TO EXTEND MATURITY FOR TERM LOANS TO SEPT 1, 2027

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment